Warsaw-listed CRO, Selvita, has acquired 100% of shares in Poland-based PozLab, a CDMO offering expert drug product development services and small pilot plant capabilities, including analytical, formulation, and process development…
Poland: Selvita expands capabilities with completion of PozLab acquisition
…
…






